CN Stock MarketDetailed Quotes
300255 Hebei Changshan Biochemical Pharmaceutical
- 18.95
- -2.15-10.19%
Market Closed Nov 22 15:00 CST
17.42BMarket Cap-20620P/E (TTM)
20.95High18.95Low412.24KlotVolume20.71Open21.10Pre Close818.87MTurnover4.50%Turnover RatioLossP/E (Static)919.06MShares25.8852wk High9.58P/B17.36BFloat Cap7.5652wk Low25.32Limit Up915.91MShs Float25.88Historical High16.88Limit Down9.48%Amplitude1.83Historical Low--Dividend TTM19.86Avg Price236.36KlotAsk--Div YieldTTM100Lot Size157.33KlotBid
Hebei Changshan Biochemical Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -40.29%787.27M | -31.91%630.67M | -44.39%287.49M | -32.96%1.55B | -28.40%1.32B | -18.84%926.19M | -8.87%516.94M | -28.35%2.31B | -22.79%1.84B | -31.79%1.14B |
| Refunds of taxes and levies | 4,524.36%33.26M | 17,433.25%28.19M | 5,436.11%8.9M | -98.68%751.48K | -98.04%719.13K | -99.56%160.77K | --160.74K | 1,139.15%57.13M | 717.14%36.7M | 6,336.26%36.7M |
| Cash received relating to other operating activities | -43.23%42.43M | -44.92%28.02M | -67.14%7.66M | 3.67%48.43M | 39.56%74.74M | 64.75%50.87M | 691.92%23.31M | -9.33%46.71M | 191.60%53.55M | 51.68%30.88M |
| Cash inflows from operating activities | -38.09%862.96M | -29.71%686.88M | -43.74%304.05M | -33.81%1.6B | -27.84%1.39B | -19.15%977.22M | -5.23%540.41M | -26.42%2.42B | -19.78%1.93B | -28.65%1.21B |
| Goods services cash paid | -52.80%377.8M | -62.48%235.71M | -81.19%63.25M | -43.87%782.48M | -34.25%800.36M | -26.86%628.2M | -16.63%336.33M | -22.43%1.39B | -10.23%1.22B | 13.49%858.86M |
| Staff behalf paid | -0.07%135.97M | 7.86%92.7M | 11.42%50.87M | 3.16%177.13M | 6.41%136.06M | -1.06%85.94M | -2.27%45.66M | 25.89%171.7M | 27.63%127.87M | 30.47%86.86M |
| All taxes paid | -70.06%44.45M | -65.63%42.04M | -79.60%17.42M | 17.70%150.58M | 51.62%148.47M | 42.49%122.34M | 114.85%85.36M | -24.00%127.93M | -41.26%97.92M | -40.85%85.85M |
| Cash paid relating to other operating activities | -64.30%154.39M | -62.35%115.13M | -66.11%58.56M | -36.68%456.57M | -35.69%432.45M | -33.46%305.84M | -27.69%172.8M | -38.95%721.1M | -27.50%672.41M | -24.28%459.61M |
| Cash outflows from operating activities | -53.04%712.61M | -57.49%485.59M | -70.30%190.11M | -35.12%1.57B | -28.27%1.52B | -23.40%1.14B | -12.17%640.15M | -26.45%2.41B | -17.05%2.12B | -5.35%1.49B |
| Net cash flows from operating activities | 221.88%150.35M | 221.93%201.29M | 214.23%113.94M | 979.06%33.73M | 32.86%-123.36M | 41.55%-165.09M | 37.14%-99.74M | 8.85%3.13M | -29.24%-183.72M | -338.16%-282.44M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | --25M | ---- | ---- | ---- | ---- | --403.08K | --403.08K |
| Cash received from returns on investments | ---- | ---- | ---- | --7.02K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | 2,984.14%22.36K | ---- | ---- | ---- | --725 | ---- | ---- |
| Cash received relating to other investing activities | 42.69%625K | 508.96%2.52M | 232.03%425K | 113.69%4.81M | -77.65%438K | -74.51%413K | -91.29%128K | -76.86%2.25M | -65.29%1.96M | -33.09%1.62M |
| Cash inflows from investing activities | 42.69%625K | 508.96%2.52M | 232.03%425K | 1,225.68%29.84M | -81.46%438K | -79.59%413K | -93.17%128K | -76.85%2.25M | -58.15%2.36M | -16.44%2.02M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -38.62%117.91M | -34.41%93.54M | -49.73%48.2M | -44.50%239.32M | -39.07%192.1M | -38.25%142.61M | -33.60%95.87M | 39.97%431.22M | 82.89%315.3M | 109.71%230.97M |
| Cash paid to acquire investments | ---- | ---- | ---- | --25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 19.38%998K | -15.73%568K | 45.55%409K | 85.23%4.36M | -56.23%836K | -60.77%674K | -49.64%281K | -73.68%2.35M | -37.46%1.91M | -10.43%1.72M |
| Cash outflows from investing activities | -38.37%118.91M | -34.32%94.11M | -49.45%48.61M | -38.03%268.68M | -39.18%192.94M | -38.42%143.29M | -33.66%96.15M | 36.76%433.58M | 80.79%317.21M | 107.65%232.68M |
| Net cash flows from investing activities | 38.56%-118.28M | 35.89%-91.6M | 49.83%-48.18M | 44.62%-238.85M | 38.86%-192.5M | 38.06%-142.87M | 32.88%-96.03M | -40.36%-431.32M | -85.41%-314.85M | -110.40%-230.66M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 43.42%1.71B | 11.29%928M | 97.27%506M | -52.18%1.35B | -36.06%1.19B | -35.13%833.83M | -41.59%256.5M | 78.03%2.82B | 39.17%1.86B | 143.92%1.29B |
| Cash received relating to other financing activities | ---- | -89.09%1.2M | --1.19M | 284.62%25M | --2.5M | --11M | ---- | -81.63%6.5M | ---- | ---- |
| Cash inflows from financing activities | 43.12%1.71B | 9.99%929.2M | 97.73%507.19M | -51.40%1.37B | -35.92%1.19B | -34.28%844.83M | -41.59%256.5M | 74.54%2.82B | 39.17%1.86B | 143.92%1.29B |
| Borrowing repayment | 25.15%1.56B | 21.24%862.1M | 77.70%443.38M | -24.69%1.53B | -10.25%1.25B | 18.70%711.05M | 315.45%249.51M | 71.70%2.03B | 52.60%1.39B | -13.93%599.05M |
| Dividend interest payment | -0.59%81.49M | -4.56%55.7M | 22.21%28.79M | -13.12%107.73M | -11.99%81.97M | -12.57%58.36M | 18.33%23.56M | 100.35%124M | 92.47%93.14M | 99.18%66.75M |
| Cash payments relating to other financing activities | --13.44M | --13.44M | --9.49M | 100.22%30.3M | ---- | ---- | ---- | -49.56%15.13M | 25.00%2.5M | ---- |
| Cash outflows from financing activities | 24.58%1.65B | 21.03%931.24M | 76.39%481.66M | -23.16%1.67B | -10.51%1.33B | 15.56%769.41M | 241.47%273.07M | 70.23%2.17B | 54.55%1.48B | -8.86%665.81M |
| Net cash flows from financing activities | 137.39%51.02M | -102.71%-2.04M | 254.13%25.53M | -145.14%-294.94M | -136.32%-136.47M | -87.83%75.41M | -104.61%-16.56M | 90.53%653.44M | -0.11%375.69M | 404.47%619.66M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -92.23%244.41K | -93.80%231.69K | 72.36%-208.03K | -76.59%3.03M | -82.79%3.15M | -49.71%3.73M | 52.96%-752.57K | 471.08%12.96M | 1,530.49%18.27M | 608.24%7.43M |
| Net increase in cash and cash equivalents | 118.55%83.33M | 147.15%107.88M | 142.74%91.08M | -308.66%-497.03M | -329.39%-449.18M | -300.74%-228.82M | -481.74%-213.09M | 579.85%238.2M | -266.40%-104.61M | 158.15%113.98M |
| Add:Begin period cash and cash equivalents | -68.28%230.86M | -68.28%230.86M | -68.28%230.86M | 48.64%727.89M | 48.75%727.89M | 48.75%727.89M | 48.75%727.89M | 7.71%489.69M | 7.63%489.34M | 7.63%489.34M |
| End period cash equivalent | 12.73%314.19M | -32.13%338.74M | -37.46%321.94M | -68.28%230.86M | -27.56%278.71M | -17.28%499.08M | -5.57%514.8M | 48.64%727.89M | -25.66%384.73M | 133.28%603.33M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data